AAAAAA

   
Results: 1-25 | 26-50 | 51-56
Results: 1-25/56
COMMENTARY ON THE 6TH REPORT OF THE JOINT-NATIONAL-COMMITTEE (JNC-6)
Authors: KAPLAN NM
Citation: Nm. Kaplan, COMMENTARY ON THE 6TH REPORT OF THE JOINT-NATIONAL-COMMITTEE (JNC-6), American journal of hypertension, 11(1), 1998, pp. 134-136
NEW JNC-6 GUIDELINES
Authors: KAPLAN NM
Citation: Nm. Kaplan, NEW JNC-6 GUIDELINES, American journal of kidney diseases, 31(5), 1998, pp. 864-865
OBESITY IN HYPERTENSION - EFFECTS ON PROGNOSIS AND TREATMENT
Authors: KAPLAN NM
Citation: Nm. Kaplan, OBESITY IN HYPERTENSION - EFFECTS ON PROGNOSIS AND TREATMENT, Journal of hypertension, 16, 1998, pp. 35-37
VENTROLATERAL MEDULLARY DECOMPRESSION IN ESSENTIAL-HYPERTENSION
Authors: KAPLAN NM
Citation: Nm. Kaplan, VENTROLATERAL MEDULLARY DECOMPRESSION IN ESSENTIAL-HYPERTENSION, Lancet, 352(9139), 1998, pp. 1549-1550
JNC VI GUIDELINES
Authors: KAPLAN NM
Citation: Nm. Kaplan, JNC VI GUIDELINES, Lancet, 351(9098), 1998, pp. 288-288
EXECUTIVE SUMMARIES ON HYPERTENSION III - MANAGING DIFFICULT-TO-TREATHYPERTENSION
Authors: KAPLAN NM
Citation: Nm. Kaplan, EXECUTIVE SUMMARIES ON HYPERTENSION III - MANAGING DIFFICULT-TO-TREATHYPERTENSION, Medicamentos de actualidad, 34(2), 1998, pp. 139-143
EXECUTIVE SUMMARIES ON HYPERTENSION - II - CHOICES OF INITIAL-DRUG THERAPY
Authors: KAPLAN NM
Citation: Nm. Kaplan, EXECUTIVE SUMMARIES ON HYPERTENSION - II - CHOICES OF INITIAL-DRUG THERAPY, Medicamentos de actualidad, 34(1), 1998, pp. 17-23
KAPLAN,NORMAN,MAYER, MD - A CONVERSATION WITH THE EDITOR
Authors: ROBARTS WC KAPLAN NM
Citation: Wc. Robarts et Nm. Kaplan, KAPLAN,NORMAN,MAYER, MD - A CONVERSATION WITH THE EDITOR, The American journal of cardiology, 82(4), 1998, pp. 490-504
TREATMENT OF HYPERTENSION - INSIGHTS FROM THE JNC-VI REPORT
Authors: KAPLAN NM
Citation: Nm. Kaplan, TREATMENT OF HYPERTENSION - INSIGHTS FROM THE JNC-VI REPORT, American family physician, 58(6), 1998, pp. 1323-1330
PERSPECTIVES ON THE NEW JNC-VI GUIDELINES FOR THE TREATMENT OF HYPERTENSION
Authors: KAPLAN NM
Citation: Nm. Kaplan, PERSPECTIVES ON THE NEW JNC-VI GUIDELINES FOR THE TREATMENT OF HYPERTENSION, Formulary, 32(12), 1997, pp. 1224-1231
COMBINATION THERAPY - A KEY TO COMPREHENSIVE PATIENT-CARE
Authors: KAPLAN NM SEVER PS
Citation: Nm. Kaplan et Ps. Sever, COMBINATION THERAPY - A KEY TO COMPREHENSIVE PATIENT-CARE, American journal of hypertension, 10(7), 1997, pp. 127-127
THE CHALLENGE OF MANAGING MULTIPLE CARDIOVASCULAR RISK-FACTORS
Authors: KAPLAN NM
Citation: Nm. Kaplan, THE CHALLENGE OF MANAGING MULTIPLE CARDIOVASCULAR RISK-FACTORS, American journal of hypertension, 10(7), 1997, pp. 167-169
EXECUTIVE SUMMARIES ON HYPERTENSION I - INITIAL EVALUATION AND NONDRUG THERAPIES
Authors: KAPLAN NM
Citation: Nm. Kaplan, EXECUTIVE SUMMARIES ON HYPERTENSION I - INITIAL EVALUATION AND NONDRUG THERAPIES, Medicamentos de actualidad, 33(10), 1997, pp. 707-713
ANXIETY-INDUCED HYPERVENTILATION - A COMMON-CAUSE OF SYMPTOMS IN PATIENTS WITH HYPERTENSION
Authors: KAPLAN NM
Citation: Nm. Kaplan, ANXIETY-INDUCED HYPERVENTILATION - A COMMON-CAUSE OF SYMPTOMS IN PATIENTS WITH HYPERTENSION, Archives of internal medicine, 157(9), 1997, pp. 945-948
THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE
Authors: BLACK HR COHEN JD KAPLAN NM FERDINAND KC CHOBANIAN AV DUSTAN HP GIFFORD RW MOSER M SHEPS SG AGODOA L AUGUST PA BAKRIS GL BURT V BUSSE W CARTER BL CHESLEY FD CLEEMAN J COHN JN CREGLER LL CRESPO C CUSHMAN WC CUTLER J DARROW MD DEQUATTRO VL DEVEREUX RB DWORKIN LD ELLIOTT WJ EPSTEIN M FALKNER B FERRARIO CM FLACK JM FRISHMAN W FROHLICH ED GREEN LA GRIMM RH HAGBERG JM HALL WD HANDLER J HAVAS S HILL MN HORAN MJ HSUEH WA HYMAN BN IZZO JL JAMERSON K KILEY JP KOCHAR MS KOLASA KM KRAKOFF LR LEVY D LINDHEIMER MD LUEPKER RV MALONE MEL MASSIE B MATERSON BJ MERCHANT J MESSERLI FH MILLER NH MOORE MA MUSTONEALEXANDER L OPARIL S PERRY HM PICKERING TG PRATT JH RAM CVS RANDALL OS REED JW ROBERTS RW ROCCELLA EJ ROGUS SD SAUNDERS E SCHRON E SCHWARTZ G SIBAI BM SNYDER D SOWERS JR STAMLER J TEMPLE R TEXTOR S THOM T VIDT DG WEBER M WEINBERGER MH WEINSHILBOUM R WHELTON PK WHISNANT JP WIEBERS DO WINSTON MC WRIGHT JT LENFANT C CASSER L COLMAN PJ EDWARDS T FEELEY DM GAJEWSKI J LEVINE D MANGER W MARSHALL EC NICKEY WA ROBERT RW SECREST BG SINGER EH WHISNANT JP WILSON GJ YOUNG JM BACHMAN JW CAMPESE VM CARR AA HAND M HOLDEN DC JAMIESON MJ JULIUS S MENSAH GA PRISANT M SULLIVAN JM WILSON DJ MOROSCO G ANDERSON DE WAUGH D
Citation: Hr. Black et al., THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE, Archives of internal medicine, 157(21), 1997, pp. 2413-2446
NEW ADVANCES IN IMMUNOSUPPRESSION THERAPY FOR RENAL-TRANSPLANTATION
Authors: KAPLAN NM PALMER BF VAZQUEZ MA
Citation: Nm. Kaplan et al., NEW ADVANCES IN IMMUNOSUPPRESSION THERAPY FOR RENAL-TRANSPLANTATION, The American journal of the medical sciences, 314(6), 1997, pp. 415-435
BETA-BLOCKADE IN THE PRIMARY PREVENTION OF HYPERTENSIVE CARDIOVASCULAR EVENTS WITH FOCUS ON SUDDEN CARDIAC DEATH
Authors: KAPLAN NM
Citation: Nm. Kaplan, BETA-BLOCKADE IN THE PRIMARY PREVENTION OF HYPERTENSIVE CARDIOVASCULAR EVENTS WITH FOCUS ON SUDDEN CARDIAC DEATH, The American journal of cardiology, 80(9B), 1997, pp. 20-22
COST CONSIDERATIONS IN THE DRUG-TREATMENT OF HYPERTENSION - IS OLDER BETTER
Authors: KAPLAN NM
Citation: Nm. Kaplan, COST CONSIDERATIONS IN THE DRUG-TREATMENT OF HYPERTENSION - IS OLDER BETTER, PharmacoEconomics, 9(4), 1996, pp. 283-285
THE CARE STUDY - A POSTMARKETING EVALUATION OF RAMIPRIL IN 11,100 PATIENTS
Authors: KAPLAN NM
Citation: Nm. Kaplan, THE CARE STUDY - A POSTMARKETING EVALUATION OF RAMIPRIL IN 11,100 PATIENTS, Clinical therapeutics, 18(4), 1996, pp. 658-670
DO CALCIUM-ANTAGONISTS CAUSE CANCER
Authors: KAPLAN NM
Citation: Nm. Kaplan, DO CALCIUM-ANTAGONISTS CAUSE CANCER, Lancet, 348(9026), 1996, pp. 541-541
MEDICINE AND THE MEDIA
Authors: KAPLAN NM
Citation: Nm. Kaplan, MEDICINE AND THE MEDIA, Lancet, 348(9022), 1996, pp. 270-270
DEAR DOCTOR ... REGARDING CALCIUM-CHANNEL BLOCKERS
Authors: KAPLAN NM
Citation: Nm. Kaplan, DEAR DOCTOR ... REGARDING CALCIUM-CHANNEL BLOCKERS, JAMA, the journal of the American Medical Association, 275(7), 1996, pp. 518-518
CHOICE OF INITIAL THERAPY FOR HYPERTENSION
Authors: KAPLAN NM GIFFORD RW
Citation: Nm. Kaplan et Rw. Gifford, CHOICE OF INITIAL THERAPY FOR HYPERTENSION, JAMA, the journal of the American Medical Association, 275(20), 1996, pp. 1577-1580
ALPHA-BLOCKADE - MONOTHERAPY FOR HYPERTENSION AND BENIGN PROSTATIC HYPERPLASIA
Authors: KAPLAN SA KAPLAN NM
Citation: Sa. Kaplan et Nm. Kaplan, ALPHA-BLOCKADE - MONOTHERAPY FOR HYPERTENSION AND BENIGN PROSTATIC HYPERPLASIA, Urology, 48(4), 1996, pp. 541-550
CALCIUM-CHANNEL BLOCKERS - RESOLVING THE CONTROVERSY
Authors: KAPLAN NM
Citation: Nm. Kaplan, CALCIUM-CHANNEL BLOCKERS - RESOLVING THE CONTROVERSY, Medicamentos de actualidad, 32(7), 1996, pp. 567-572
Risultati: 1-25 | 26-50 | 51-56